TY - STD TI - IDF Diabetes Atlas.http://www.idf.org/diabetesatlas/. UR - http://www.idf.org/diabetesatlas/ ID - ref1 ER - TY - JOUR AU - Inzucchi, S. E. AU - Bergenstal, R. M. AU - Buse, J. B. AU - Diamant, M. AU - Ferrannini, E. AU - Nauck, M. AU - Peters, A. L. AU - Tsapas, A. AU - Wender, R. AU - Matthews, D. R. PY - 2012 DA - 2012// TI - Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) JO - Diabetologia VL - 55 UR - https://doi.org/10.1007/s00125-012-2534-0 DO - 10.1007/s00125-012-2534-0 ID - Inzucchi2012 ER - TY - JOUR AU - Basi, S. AU - Fesler, P. AU - Mimran, A. AU - Lewis, J. B. PY - 2008 DA - 2008// TI - Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander? JO - Diabetes Care VL - 31 UR - https://doi.org/10.2337/dc08-s249 DO - 10.2337/dc08-s249 ID - Basi2008 ER - TY - JOUR AU - Chade, A. R. AU - Lerman, A. AU - Lerman, L. O. PY - 2005 DA - 2005// TI - Kidney in early atherosclerosis JO - Hypertension VL - 45 UR - https://doi.org/10.1161/01.HYP.0000167121.14254.a0 DO - 10.1161/01.HYP.0000167121.14254.a0 ID - Chade2005 ER - TY - JOUR PY - 2012 DA - 2012// TI - Standards of medical care in diabetes—2012 JO - Diabetes Care VL - 35 ID - ref5 ER - TY - JOUR PY - 2012 DA - 2012// TI - KDOQI clinical practice guideline for diabetes and CKD: 2012 update JO - Am J Kidney Dis VL - 60 UR - https://doi.org/10.1053/j.ajkd.2012.07.005 DO - 10.1053/j.ajkd.2012.07.005 ID - ref6 ER - TY - JOUR AU - Del Prato, S. AU - Barnett, A. H. AU - Huisman, H. AU - Neubacher, D. AU - Woerle, H. J. AU - Dugi, K. A. PY - 2011 DA - 2011// TI - Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2010.01350.x DO - 10.1111/j.1463-1326.2010.01350.x ID - Del Prato2011 ER - TY - JOUR AU - Owens, D. R. AU - Swallow, R. AU - Dugi, K. A. AU - Woerle, H. J. PY - 2011 DA - 2011// TI - Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study JO - Diabet Med VL - 28 UR - https://doi.org/10.1111/j.1464-5491.2011.03387.x DO - 10.1111/j.1464-5491.2011.03387.x ID - Owens2011 ER - TY - JOUR AU - Taskinen, M. R. AU - Rosenstock, J. AU - Tamminen, I. AU - Kubiak, R. AU - Patel, S. AU - Dugi, K. A. AU - Woerle, H. J. PY - 2011 DA - 2011// TI - Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2010.01326.x DO - 10.1111/j.1463-1326.2010.01326.x ID - Taskinen2011 ER - TY - JOUR AU - Johansen, O. E. AU - Neubacher, D. AU - von Eynatten, M. AU - Patel, S. AU - Woerle, H. J. PY - 2012 DA - 2012// TI - Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme JO - Cardiovasc Diabetol VL - 11 UR - https://doi.org/10.1186/1475-2840-11-3 DO - 10.1186/1475-2840-11-3 ID - Johansen2012 ER - TY - JOUR AU - Schernthaner, G. AU - Barnett, A. H. AU - Emser, A. AU - Patel, S. AU - Troost, J. AU - Woerle, H. J. AU - von Eynatten, M. PY - 2012 DA - 2012// TI - Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2012.01565.x DO - 10.1111/j.1463-1326.2012.01565.x ID - Schernthaner2012 ER - TY - STD TI - Boehringer Ingelheim International GmbH: TradjentaTM (linagliptin) tablets. US prescribing information, 2011.  .  ,  :  . ID - ref12 ER - TY - JOUR AU - Barnett, A. H. AU - Patel, S. AU - Harper, R. AU - Toorawa, R. AU - Thiemann, S. AU - von Eynatten, M. AU - Woerle, H. J. PY - 2012 DA - 2012// TI - Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension JO - Diabetes Obes Metab VL - 14 ID - Barnett2012 ER - TY - JOUR AU - Lewin, A. J. AU - Arvay, L. AU - Liu, D. AU - Patel, S. AU - von Eynatten, M. AU - Woerle, H. J. PY - 2012 DA - 2012// TI - Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, Placebo-Controlled Trial JO - Clin Ther VL - 1909–1919 ID - Lewin2012 ER - TY - JOUR AU - Gomis, R. AU - Espadero, R. M. AU - Jones, R. AU - Woerle, H. J. AU - Dugi, K. A. PY - 2011 DA - 2011// TI - Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2011.01391.x DO - 10.1111/j.1463-1326.2011.01391.x ID - Gomis2011 ER - TY - JOUR AU - Adler, A. I. AU - Stevens, R. J. AU - Manley, S. E. AU - Bilous, R. W. AU - Cull, C. A. AU - Holman, R. R. PY - 2003 DA - 2003// TI - Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) JO - Kidney Int VL - 63 UR - https://doi.org/10.1046/j.1523-1755.2003.00712.x DO - 10.1046/j.1523-1755.2003.00712.x ID - Adler2003 ER - TY - JOUR AU - de Zeeuw, D. PY - 2007 DA - 2007// TI - Albuminuria: a target for treatment of type 2 diabetic nephropathy JO - Semin Nephrol VL - 27 UR - https://doi.org/10.1016/j.semnephrol.2007.01.002 DO - 10.1016/j.semnephrol.2007.01.002 ID - de Zeeuw2007 ER - TY - JOUR AU - Ritz, E. AU - Schmieder, R. E. AU - Pollock, C. A. PY - 2010 DA - 2010// TI - Renal protection in diabetes: lessons from ONTARGET JO - Cardiovasc Diabetol VL - 9 UR - https://doi.org/10.1186/1475-2840-9-60 DO - 10.1186/1475-2840-9-60 ID - Ritz2010 ER - TY - STD TI - International Diabetes Federation: Global guideline for type 2 diabetes.http://www.idf.org/global-guideline-type-2-diabetes-2012. UR - http://www.idf.org/global-guideline-type-2-diabetes-2012 ID - ref19 ER - TY - JOUR AU - Bakris, G. L. PY - 2011 DA - 2011// TI - Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus JO - Mayo Clin Proc VL - 86 UR - https://doi.org/10.4065/mcp.2010.0713 DO - 10.4065/mcp.2010.0713 ID - Bakris2011 ER - TY - JOUR AU - Chacra, A. R. AU - Tan, G. H. AU - Apanovitch, A. AU - Ravichandran, S. AU - List, J. AU - Chen, R. PY - 2009 DA - 2009// TI - Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial JO - Int J Clin Pract VL - 63 UR - https://doi.org/10.1111/j.1742-1241.2009.02143.x DO - 10.1111/j.1742-1241.2009.02143.x ID - Chacra2009 ER - TY - JOUR AU - Hermansen, K. AU - Kipnes, M. AU - Luo, E. AU - Fanurik, D. AU - Khatami, H. AU - Stein, P. PY - 2007 DA - 2007// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin JO - Diabetes Obes Metab VL - 9 UR - https://doi.org/10.1111/j.1463-1326.2007.00744.x DO - 10.1111/j.1463-1326.2007.00744.x ID - Hermansen2007 ER - TY - JOUR AU - Meloni, A. R. AU - Deyoung, M. B. AU - Lowe, C. AU - Parkes, D. G. PY - 2013 DA - 2013// TI - GLP-1 receptor activated insulin secretion from pancreatic beta-cells: mechanism and glucose dependence JO - Diabetes Obes Metab VL - 15 UR - https://doi.org/10.1111/j.1463-1326.2012.01663.x DO - 10.1111/j.1463-1326.2012.01663.x ID - Meloni2013 ER - TY - JOUR AU - Tremblay, A. J. AU - Lamarche, B. AU - Deacon, C. F. AU - Weisnagel, S. J. AU - Couture, P. PY - 2011 DA - 2011// TI - Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2011.01362.x DO - 10.1111/j.1463-1326.2011.01362.x ID - Tremblay2011 ER - TY - JOUR AU - Matikainen, N. AU - Manttari, S. AU - Schweizer, A. AU - Ulvestad, A. AU - Mills, D. AU - Dunning, B. E. AU - Foley, J. E. AU - Taskinen, M. R. PY - 2006 DA - 2006// TI - Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes JO - Diabetologia VL - 49 UR - https://doi.org/10.1007/s00125-006-0340-2 DO - 10.1007/s00125-006-0340-2 ID - Matikainen2006 ER - TY - JOUR AU - Cobble, M. E. AU - Frederich, R. PY - 2012 DA - 2012// TI - Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data JO - Cardiovasc Diabetol VL - 11 UR - https://doi.org/10.1186/1475-2840-11-6 DO - 10.1186/1475-2840-11-6 ID - Cobble2012 ER - TY - JOUR AU - Ogawa, S. AU - Ishiki, M. AU - Nako, K. AU - Okamura, M. AU - Senda, M. AU - Mori, T. AU - Ito, S. PY - 2011 DA - 2011// TI - Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetes JO - Tohoku J Exp Med VL - 223 UR - https://doi.org/10.1620/tjem.223.133 DO - 10.1620/tjem.223.133 ID - Ogawa2011 ER - TY - JOUR AU - Russell-Jones, D. AU - Cuddihy, R. M. AU - Hanefeld, M. AU - Kumar, A. AU - Gonzalez, J. G. AU - Chan, M. AU - Wolka, A. M. AU - Boardman, M. K. PY - 2012 DA - 2012// TI - Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study JO - Diabetes Care VL - 35 UR - https://doi.org/10.2337/dc11-1107 DO - 10.2337/dc11-1107 ID - Russell-Jones2012 ER - TY - JOUR AU - Groop, P. -. H. AU - Cooper, M. AU - Perkovic, V. AU - Emser, A. AU - Seck, T. AU - von Eynatten, M. AU - Woerle, H. -. J. PY - 2012 DA - 2012// TI - Effects of the DPP-4 inhibitor linagliptin on albuminuria in patients with type 2 diabetes and diabetic nephropathy JO - Diabetologia VL - 55 ID - Groop2012 ER - TY - JOUR AU - Chan, J. C. AU - Scott, R. AU - Arjona Ferreira, J. C. AU - Sheng, D. AU - Gonzalez, E. AU - Davies, M. J. AU - Stein, P. P. AU - Kaufman, K. D. AU - Amatruda, J. M. AU - Williams-Herman, D. PY - 2008 DA - 2008// TI - Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency JO - Diabetes Obes Metab VL - 10 UR - https://doi.org/10.1111/j.1463-1326.2008.00914.x DO - 10.1111/j.1463-1326.2008.00914.x ID - Chan2008 ER - TY - JOUR AU - Nowicki, M. AU - Rychlik, I. AU - Haller, H. AU - Warren, M. L. AU - Suchower, L. AU - Gause-Nilsson, I. PY - 2011 DA - 2011// TI - Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2011.01382.x DO - 10.1111/j.1463-1326.2011.01382.x ID - Nowicki2011 ER - TY - JOUR AU - Graefe-Mody, U. AU - Friedrich, C. AU - Port, A. AU - Ring, A. AU - Retlich, S. AU - Heise, T. AU - Halabi, A. AU - Woerle, H. J. PY - 2011 DA - 2011// TI - Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*) JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2011.01458.x DO - 10.1111/j.1463-1326.2011.01458.x ID - Graefe-Mody2011 ER - TY - JOUR AU - McGill, J. B. AU - Sloan, L. AU - Newman, J. AU - Patel, S. AU - Sauce, C. AU - von Eynatten, M. AU - Woerle, H. J. PY - 2013 DA - 2013// TI - Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study JO - Diabetes Care VL - 36 UR - https://doi.org/10.2337/dc12-0706 DO - 10.2337/dc12-0706 ID - McGill2013 ER - TY - JOUR AU - Gallwitz, B. AU - Rosenstock, J. AU - Rauch, T. AU - Bhattacharya, S. AU - Patel, S. AU - von Eynatten, M. AU - Dugi, K. A. AU - Woerle, H. J. PY - 2012 DA - 2012// TI - 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)60691-6 DO - 10.1016/S0140-6736(12)60691-6 ID - Gallwitz2012 ER -